What are Bio-Rad Laboratories, Inc.'s profit margins?

Bio-Rad Laboratories, Inc. (BIO.B) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.

Where do Bio-Rad Laboratories, Inc.'s ratios come from?

Every ratio is computed from Bio-Rad Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Bio-Rad Laboratories, Inc. BIO.B Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	51.9%0.0pp	51.9%-0.4pp	52.3%-0.6pp	52.8%-0.7pp	53.5%-0.2pp
Net margin	6.5%-22.9pp	29.4%+55.8pp	-26.4%-38.9pp	12.5%+97.7pp	-85.2%-13.3pp
Free cash flow margin	13.8%-0.7pp	14.5%+1.3pp	13.2%-1.4pp	14.5%+0.5pp	14%+2.7pp
Returns
Return on equity	2.5%-8.3pp	10.8%+20.3pp	-9.5%-14.1pp	4.6%+32.1pp	-27.5%-3.4pp
Return on assets	1.7%-5.9pp	7.6%+14.3pp	-6.7%-9.9pp	3.2%+22.8pp	-19.6%-2.5pp
Return on invested capital	11.4%+0.7pp	10.7%+7.9pp	2.8%+0.8pp	2%-0.8pp	2.8%-0.3pp
Efficiency
Asset turnover	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.2×0.0×
Inventory turnover	1.6×-0.1×	1.7×+0.1×	1.5×0.0×	1.5×0.0×	1.5×0.0×
Liquidity
Current ratio	3.2×-2.4×	5.6×+0.2×	5.4×+0.3×	5.1×-0.9×	6×-0.5×
Quick ratio	2.4×-1.8×	4.2×+0.2×	3.9×+0.3×	3.7×-0.8×	4.4×-0.4×
Cash ratio	0.6×-0.5×	1×+0.3×	0.8×+0.1×	0.7×-0.4×	1×0.0×
Leverage
Debt-to-equity	0.1×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Interest coverage	22.7×+0.1×	22.6×+18.0×	4.6×0.0×	4.6×-0.5×	5.1×-0.4×
Per Share
Book value per share	$254.15-7.0%	$273.22+9.2%	$250.22-4.4%	$261.82+9.6%	$238.93+2.6%
Valuation
Market capitalization	$7.52B-7.9%	$8.17B+7.7%	$7.59B+17.2%	$6.47B-5.1%	$6.82B-25.8%
Enterprise value	$8B-11.4%	$9.03B+5.1%	$8.59B+14.3%	$7.52B-2.1%	$7.68B-23.9%
Price / sales	2.9×-0.3×	3.2×+0.2×	3×+0.4×	2.5×-0.2×	2.7×-0.9×
Price / book	1.1×0.0×	1.1×0.0×	1.1×+0.2×	0.9×-0.1×	1×-0.4×
EV / sales	3.1×-0.4×	3.5×+0.1×	3.4×+0.4×	2.9×-0.1×	3×-0.9×
Free cash flow yield	4.7%+0.2pp	4.6%+0.1pp	4.4%-1.3pp	5.7%+0.5pp	5.2%+2.1pp
Earnings yield	2.2%-7.1pp	9.3%+18.2pp	-8.9%-13.8pp	4.9%+36.7pp	-31.7%-11.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bio-Rad Laboratories, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Bio-Rad Laboratories, Inc.'s profit margins?: Bio-Rad Laboratories, Inc. (BIO.B) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.
Where do Bio-Rad Laboratories, Inc.'s ratios come from?: Every ratio is computed from Bio-Rad Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.